Kintegral Advisory LLC trimmed its position in Aflac Incorporated (NYSE:AFL – Free Report) by 4.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 43,456 shares of the financial services provider’s stock after selling 2,025 shares during the period. Kintegral Advisory LLC’s holdings in Aflac were worth $4,495,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in AFL. Spinnaker Trust raised its position in shares of Aflac by 2.7% during the 3rd quarter. Spinnaker Trust now owns 3,620 shares of the financial services provider’s stock valued at $405,000 after acquiring an additional 95 shares in the last quarter. Phillips Wealth Planners LLC raised its holdings in shares of Aflac by 1.5% during the fourth quarter. Phillips Wealth Planners LLC now owns 6,553 shares of the financial services provider’s stock worth $662,000 after purchasing an additional 100 shares during the period. Raleigh Capital Management Inc. raised its holdings in shares of Aflac by 23.2% during the fourth quarter. Raleigh Capital Management Inc. now owns 531 shares of the financial services provider’s stock worth $55,000 after purchasing an additional 100 shares during the period. TKG Advisors LLC lifted its position in shares of Aflac by 0.5% in the 4th quarter. TKG Advisors LLC now owns 21,255 shares of the financial services provider’s stock worth $2,230,000 after buying an additional 103 shares during the last quarter. Finally, Covestor Ltd boosted its holdings in shares of Aflac by 41.8% in the 3rd quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock valued at $41,000 after buying an additional 107 shares during the period. 67.44% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several research firms recently weighed in on AFL. Barclays dropped their price objective on shares of Aflac from $98.00 to $95.00 and set an “underweight” rating on the stock in a research note on Friday, February 7th. StockNews.com upgraded Aflac from a “sell” rating to a “hold” rating in a research report on Friday, February 14th. Keefe, Bruyette & Woods reduced their price objective on Aflac from $107.00 to $104.00 and set a “market perform” rating for the company in a research report on Wednesday, February 12th. Wells Fargo & Company dropped their target price on Aflac from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research report on Wednesday. Finally, BMO Capital Markets began coverage on Aflac in a research note on Thursday, January 23rd. They issued a “market perform” rating and a $111.00 target price on the stock. Two research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, Aflac has a consensus rating of “Hold” and an average price target of $102.86.
Insider Buying and Selling at Aflac
In related news, EVP Audrey B. Tillman sold 24,744 shares of the business’s stock in a transaction that occurred on Friday, December 27th. The shares were sold at an average price of $103.40, for a total value of $2,558,529.60. Following the sale, the executive vice president now directly owns 222,618 shares in the company, valued at $23,018,701.20. The trade was a 10.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.90% of the stock is owned by corporate insiders.
Aflac Trading Down 2.1 %
Shares of NYSE:AFL opened at $102.04 on Friday. Aflac Incorporated has a twelve month low of $78.62 and a twelve month high of $115.50. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29. The firm has a market cap of $56.69 billion, a P/E ratio of 10.63, a P/E/G ratio of 3.31 and a beta of 0.99. The company has a 50 day moving average of $104.11 and a 200-day moving average of $107.29.
Aflac (NYSE:AFL – Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. As a group, analysts anticipate that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.
Aflac Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Monday, March 3rd. Shareholders of record on Wednesday, February 19th will be given a $0.58 dividend. The ex-dividend date of this dividend is Wednesday, February 19th. This is a boost from Aflac’s previous quarterly dividend of $0.50. This represents a $2.32 annualized dividend and a yield of 2.27%. Aflac’s payout ratio is 24.17%.
Aflac Company Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Further Reading
- Five stocks we like better than Aflac
- What Are the U.K. Market Holidays? How to Invest and Trade
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- What is a Stock Market Index and How Do You Use Them?
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- How to Invest in Small Cap StocksĀ
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.